Showing 261 - 280 results of 107,523 for search '(( a point decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.35s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”
  6. 266
  7. 267
  8. 268

    Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  9. 269

    Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  10. 270

    Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  11. 271

    Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…The smoothest cylinder (K<sub>s</sub>/D = ) produced the highest power (52.325 µW), while the roughest (K<sub>s</sub>/D = ) resulted in a 6.26% decrease in power (36.4 µW), along with reductions of 4.5% in flapping frequency and 20% in amplitude. …”
  12. 272
  13. 273
  14. 274

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  15. 275
  16. 276
  17. 277
  18. 278
  19. 279
  20. 280

    Mice carrying 100P mutations show region-specific decreases in proportions of PV-expressing cells. by Malgorzata Borkowska (3166719)

    Published 2016
    “…<p>(<b>A</b>) Significant decreases in the proportions of PV+ cells were observed in fSSp, SSp, vAud and in Vis, but not MPFC. …”